Scout | FOR-FD-25-006: FDA funding for studies advancing products for ALS and other rare neurodegenerative diseases

forecast FOR-FD-25-006

FDA funding for studies advancing products for ALS and other rare neurodegenerative diseases

Summary

This grant aims to fund research that helps develop medical products to prevent, diagnose, or treat ALS and other rare neurodegenerative diseases in both adults and children. The goal is to fill important knowledge gaps and significantly impact the understanding and treatment of these diseases, benefiting current or future product development.

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these st…

Funding Source

Agency: Food and Drug Administration

Eligibility

Native American tribal organizations (other than Federally recognized tribal governments)

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Public and State controlled institutions of higher education

Small businesses

State governments

Supporting links

grants.gov

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers